David Montecalvo Net Worth

The estimated Net Worth of David A Montecalvo is at least $4.12 Millón dollars as of 28 July 2020. Mr. Montecalvo owns over 19,150 units of West Pharmaceutical Services stock worth over $2,897,118 and over the last 8 years he sold WST stock worth over $0. In addition, he makes $1,223,490 as Senior Vice President y Chief Operating and Supply Chain Officer at West Pharmaceutical Services.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Montecalvo WST stock SEC Form 4 insiders trading

David has made over 1 trades of the West Pharmaceutical Services stock since 2020, according to the Form 4 filled with the SEC. Most recently he exercised 19,150 units of WST stock worth $1,472,444 on 28 July 2020.

The largest trade he's ever made was exercising 19,150 units of West Pharmaceutical Services stock on 28 July 2020 worth over $1,472,444. On average, David trades about 1,064 units every 0 days since 2016. As of 28 July 2020 he still owns at least 9,582 units of West Pharmaceutical Services stock.

You can see the complete history of Mr. Montecalvo stock trades at the bottom of the page.

David Montecalvo biography

David A. Montecalvo serves as Senior Vice President, Chief Operating and Supply Chain Officer of the Company. He is Senior Vice President, Global Operations and Supply Chain from September 2016 until February 2019. Prior to joining West, he served in a number of senior leadership roles at Medtronic plc, including Vice President, Contract Manufacturing Operations, for the company’s Restorative Therapies Group, Vice President, Business Operations Integration, where he was responsible for directing and leading the global operations integration of Covidien plc into Medtronic, and Vice President, Product Development and Operations for Medtronic Cardiovascular. Prior thereto, he held senior operations and product development roles at Urologix, Inc. and LecTec Corporation.

What is the salary of David Montecalvo?

As the Senior Vice President y Chief Operating and Supply Chain Officer of West Pharmaceutical Services, the total compensation of David Montecalvo at West Pharmaceutical Services is $1,223,490. There are 6 executives at West Pharmaceutical Services getting paid more, with Eric Green having the highest compensation of $6,533,690.

How old is David Montecalvo?

David Montecalvo is 54, he's been the Senior Vice President y Chief Operating and Supply Chain Officer of West Pharmaceutical Services since 2019. There are 16 older and 9 younger executives at West Pharmaceutical Services. The oldest executive at West Pharmaceutical Services, Inc. is Patrick Zenner, 73, who is the Independent Chairman of the Board.

What's David Montecalvo's mailing address?

David's mailing address filed with the SEC is 530 HERMAN O. WEST DRIVE, , EXTON, PA, 19341.

Insiders trading at West Pharmaceutical Services

Over the last 19 years, insiders at West Pharmaceutical Services have traded over $32,829,857 worth of West Pharmaceutical Services stock and bought 19,924 units worth $1,139,950 . The most active insiders traders include Robert F Friel, Paolo Pucci y Douglas A Michels. On average, West Pharmaceutical Services executives and independent directors trade stock every 40 days with the average trade being worth of $4,786,805. The most recent stock trade was executed by Charles Witherspoon on 19 August 2024, trading 1,029 units of WST stock currently worth $308,700.

What does West Pharmaceutical Services do?

west works side-by-side with healthcare partners from concept to the patient, designing and manufacturing packaging and delivery systems that promote efficiency, reliability and safety. west leads the way with cutting-edge technologies and quality systems, a thorough understanding of global regulatory compliance, and an unmatched knowledge of relevant pharmaceutical product testing, development and packaging. west supports customers from sales, manufacturing, and research and development locations in north and south america, europe, asia and australia.

Complete history of Mr. Montecalvo stock trades at West Pharmaceutical Services

West Pharmaceutical Services executives and stock owners

West Pharmaceutical Services executives and other stock owners filed with the SEC include:

• Eric Green,
  President, Chief Executive Officer, Director
• Eric M. Green,
  Pres, CEO & Director
• Bernard Birkett,
  Chief Financial Officer, Senior Vice President
• George Miller,
  Senior Vice President, General Counsel, Corporate Secretary
• Bernard J. Birkett,
  Sr. VP & CFO
• Silji Abraham,
  Senior Vice President and Chief Digital and Transformation Officer
• David Montecalvo,
  Senior Vice President, Chief Operating and Supply Chain Officer
• Annette Favorite,
  Chief Human Resource Officer, Senior Vice President
• David A. Montecalvo,
  Sr. VP and Chief Operations & Supply Chain Officer
• Silji Abraham,
  Sr. VP & Chief Technology Officer
• Patrick Zenner,
  Independent Chairman of the Board
• Douglas Michels,
  Independent Director
• Thomas Hofmann,
  Independent Director
• Paula Johnson,
  Independent Director
• William Feehery,
  Independent Director
• Mark Buthman,
  Independent Director
• Myla Lai-Goldman,
  Independent Director
• Paolo Pucci,
  Independent Director
• Deborah Keller Tanner,
  Independent Director
• Chad Winters,
  Chief Accounting Officer, Principal Accounting Officer, Vice President, Controller
• Robert Friel,
  Independent Director
• Cindy Reiss-Clark,
  Senior Vice President of Global Market Units and Commercial Solutions
• Quintin Lai,
  Vice President - Corporate Development, Strategy and Investor Relations
• Eric Resnick,
  Chief Technology Officer, Vice President
• Richard D. Luzzi,
  Sr. VP of HR
• Annette F. Favorite,
  Chief HR Officer & Sr. VP
• Michele Polinsky,
  VP of Global Communications
• Kimberly Banks MacKay,
  Sr. VP, Gen. Counsel & Company Sec.
• Dr. Quintin J. Lai C.F.A., Ph.D.,
  VP of Strategy & Investor Relations
• Daniel Malone,
  Vice President & Controller
• William J Federici,
  VP & CFO
• John H Weiland,
  Director
• Karen Flynn,
  President, America's Region
• Heino Lennartz,
  President Europe
• Anthony Welters,
  Director
• Warwick Bedwell,
  VP Pharma Pkgs Systems Asia Pa
• John E Paproski,
  Vice President-Innovations
• Christopher G Ryan,
  President, PPS, Americas
• Rachael M Bushey,
  VP, Deputy Gen Coun & Corp Sec
• Jeffrey C Hunt,
  VP Pharma Pckg Systems
• John R Gailey,
  VP, Gen. Counsel & Sec.
• Richard D Luzzi,
  VP, Human Resourses
• L Robert Johnson,
  Director
• Michael A Anderson,
  Vice President & Treasurer
• Donald E Jr Morel,
  Chairman of the Board & CEO
• Robert C Young,
  Director
• Donald A Mc Millan,
  President Pharma Systems NA
• Steven A Ellers,
  Pres., Pharma. Systems Div.
• Geoffrey F Worden,
  Director
• John P Neafsey,
  Director
• Joseph E Abbott,
  Corporate Controller
• Dijk Ronald Van,
  President Asia Pacific
• Robert S Hargesheimer,
  President-The Tech Group
• Fabio De Sampaio Doria Filho,
  Pres., Europe & Asia Pacific
• Matthew T Mullarkey,
  Chief Operating Officer
• Robert J Keating,
  Pres., Europe & Asia Pacific
• Jenne K Britell,
  Director
• Herbert L Hugill,
  Pres. of the Americas, Pharma.
• Linda R Altemus,
  VP & Chief Compliance Officer
• Molly Joseph,
  Director
• Deborah L Keller,
  Director
• Stephen H Lockhart,
  Director
• Charles Witherspoon,
  VP & Treasurer
• Kimberly Banks Mac Kay,
  SVP, GC & Corporate Secretary